341 related articles for article (PubMed ID: 30216914)
1. Association between body mass index and clinical outcomes after new-generation drug-eluting stent implantation: Korean multi-center registry data.
Kim BG; Hong SJ; Kim BK; Ahn CM; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2018 Oct; 277():155-162. PubMed ID: 30216914
[TBL] [Abstract][Full Text] [Related]
2. Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials.
Faggioni M; Baber U; Afshar AE; Giustino G; Sartori S; Sorrentino S; Steg PG; Stefanini GG; Windecker S; Leon MB; Stone GW; Wijns W; Serruys PW; Valgimigli M; Camenzind E; Weisz G; Smits PC; Kandzari DE; Galatius S; Von Birgelen C; Jeger RV; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Dangas GD; Morice MC; Mehran R
JACC Cardiovasc Interv; 2018 Jan; 11(1):68-76. PubMed ID: 29248412
[TBL] [Abstract][Full Text] [Related]
3. Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting stent implantation: the 'obesity paradox' phenomenon is still apparent.
Patsa C; Toutouzas K; Tsiamis E; Tsioufis C; Spanos A; Karanasos A; Michelongona A; Tousoulis D; Stefanadis C
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):307-13. PubMed ID: 21917434
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
5. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.
Lee JM; Kang J; Lee E; Hwang D; Rhee TM; Park J; Kim HL; Lee SE; Han JK; Yang HM; Park KW; Na SH; Kang HJ; Koo BK; Kim HS
JACC Cardiovasc Interv; 2016 Oct; 9(20):2097-2109. PubMed ID: 27692820
[TBL] [Abstract][Full Text] [Related]
6. Comparison of long-term mortality according to obesity in patients with successful percutaneous chronic total occlusion interventions using drug-eluting stents.
Won KB; Yoon HJ; Lee SG; Cho YK; Nam CW; Hur SH; Lee SW; Lee PH; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2018 Mar; 91(4):710-716. PubMed ID: 28976619
[TBL] [Abstract][Full Text] [Related]
7. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.
Cassese S; Kufner S; Xhepa E; Byrne RA; Kreutzer J; Ibrahim T; Tiroch K; Valgimigli M; Tölg R; Fusaro M; Schunkert H; Laugwitz KL; Mehilli J; Kastrati A
Clin Res Cardiol; 2016 Jul; 105(7):575-84. PubMed ID: 26689707
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent.
Choi KH; Song YB; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Kim HS; Chun WJ; Hur SH; Han SH; Rha SW; Chae IH; Jeong JO; Heo JH; Yoon J; Lim DS; Park JS; Hong MK; Doh JH; Cha KS; Kim DI; Lee SY; Chang K; Hwang BH; Choi SY; Jeong MH; Hong SJ; Nam CW; Koo BK; Gwon HC
Circ Cardiovasc Interv; 2020 Feb; 13(2):e008543. PubMed ID: 32069106
[TBL] [Abstract][Full Text] [Related]
9. Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.
Plitt A; Claessen BE; Sartori S; Baber U; Chandrasekhar J; Aquino M; Vijay P; Elsayed S; Kovacic JC; Sweeny J; Barman N; Moreno P; Krishnan P; Demopoulos A; Dangas G; Kini AS; Mehran R; Sharma SK
Catheter Cardiovasc Interv; 2020 Sep; 96(3):558-564. PubMed ID: 31490029
[TBL] [Abstract][Full Text] [Related]
10. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
[TBL] [Abstract][Full Text] [Related]
12. Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
Song PS; Song YB; Lee JM; Hahn JY; Choi SH; Choi JH; Lee SH; Park KW; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
JACC Cardiovasc Interv; 2016 Sep; 9(18):1879-86. PubMed ID: 27592016
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis.
Giustino G; Baber U; Aquino M; Sartori S; Stone GW; Leon MB; Genereux P; Dangas GD; Chandrasekhar J; Kimura T; Salianski O; Stefanini GG; Steg PG; Windecker S; Wijns W; Serruys PW; Valgimigli M; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari DE; Galatius S; Von Birgelen C; Saporito R; Jeger RV; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
JACC Cardiovasc Interv; 2016 Apr; 9(7):674-84. PubMed ID: 27056305
[TBL] [Abstract][Full Text] [Related]
14. Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative.
Chandrasekhar J; Baber U; Sartori S; Stefanini GG; Sarin M; Vogel B; Farhan S; Camenzind E; Leon MB; Stone GW; Serruys PW; Wijns W; Steg PG; Weisz G; Chieffo A; Kastrati A; Windecker S; Morice MC; Smits PC; von Birgelen C; Mikhail GW; Itchhaporia D; Mehta L; Kim HS; Valgimigli M; Jeger RV; Kimura T; Galatius S; Kandzari D; Dangas G; Mehran R
JACC Cardiovasc Interv; 2018 Jan; 11(1):53-65. PubMed ID: 29301648
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
16. No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry.
Akin I; Tölg R; Hochadel M; Bergmann MW; Khattab AA; Schneider S; Senges J; Kuck KH; Richardt G; Nienaber CA;
JACC Cardiovasc Interv; 2012 Feb; 5(2):162-9. PubMed ID: 22361600
[TBL] [Abstract][Full Text] [Related]
17. Obesity paradox in the era of percutaneous coronary intervention with 2nd-generation drug-eluting stents: an analysis of a multicenter PCI registry.
Ueshima D; Yoshikawa S; Sasaoka T; Hatano Y; Kurihara K; Maejima Y; Isobe M; Ashikaga T
Heart Vessels; 2019 Feb; 34(2):218-226. PubMed ID: 30066238
[TBL] [Abstract][Full Text] [Related]
18. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.
Piccolo R; Pilgrim T; Heg D; Franzone A; Rat-Wirtzler J; Räber L; Silber S; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2015 Nov; 8(13):1657-66. PubMed ID: 26585615
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis.
van Zandvoort LJC; van Bommel RJ; Masdjedi K; Tovar Forero MN; Lemmert MM; Wilschut J; Diletti R; de Jaegere PPT; Zijlstra F; van Mieghem NM; Daemen J
Catheter Cardiovasc Interv; 2020 May; 95(6):1085-1091. PubMed ID: 31301161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
